Willy Logemann

Title: Innovations of Willy Logemann

Introduction

Willy Logemann is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with analgesic and anti-inflammatory properties. With a total of 3 patents, Logemann's work has the potential to impact pain management therapies.

Latest Patents

One of his latest patents involves isoindoline derivatives for treating pain. These isoindoline derivatives are disclosed with specific formulas and methods of preparation, including the reaction of o-cyano-benzylbromide with a compound and subsequent saponification. The resulting compounds exhibit both analgesic and anti-inflammatory activity. Another significant patent focuses on pyrazine 4-oxide derivatives, which are characterized by specific formulas where R groups can be hydrogen, C1-6 alkyl, or alkoxy. At least one of these R groups must be other than hydrogen, and the compounds may include carboxy, carbalkoxy, or carboxamide groups, or pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Willy Logemann has worked with various companies, including Carlo Erba S.p.a. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Logemann has collaborated with notable individuals in his field, including Raffaele Tommasini and Vittorio Ambrogi. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Willy Logemann's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving pain management therapies. His work continues to influence the industry and offers promising solutions for patients in need.